Deamplification of pfmdr1-containing amplicon on chromosome 5 in Plasmodium falciparum is associated with reduced resistance to artelinic acid in vitro

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 8, 2010, Pages 3395-3401

  Chen, Nanhua ^a   Chavchich, Marina ^a   Peters, Jennifer M ^a,b   Kyle, Dennis E ^c   Gatton, Michelle L ^b   Cheng, Qin ^a,b  

^a AUSTRALIAN ARMY MALARIA INSTITUTE   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTELINIC ACID; MEFLOQUINE;

AMPLICON; ARTICLE; GENE AMPLIFICATION; MOLECULAR CLONING; MULTIDRUG RESISTANCE; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTOZOAL GENETICS;

ANIMALS; ANTIMALARIALS; ARTEMISININS; CHROMOSOMES; DRUG RESISTANCE; GENE AMPLIFICATION; GENE DOSAGE; HUMANS; MALARIA, FALCIPARUM; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM;

EID: 77952663685     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01421-09     Document Type: Article

References (22)

1. Anderson, T. 2009. Mapping the spread of malaria drug resistance. PLoS Med. 6:e1000054.
2. Anderson, T. J. C., J. Patel, and M. T. Ferdig. 2009. Gene copy number and malaria biology. Trends Parasitol. 25:336-343.
3. Barnes, D. A., S. J. Foote, D. Galatis, D. J. Kemp, and A. F. Cowman. 1992. Selection for high-level chloroquine resistance results in deamplification of the pfmdr1 gene and increased sensitivity to mefloquine in Plasmodium falciparum. EMBO J. 11:3067-3075.
4. Basco, L. K., J. Le-Bras, Z. Rhoades, and C. M. Wilson. 1995. Analysis of pfmdr1 and drug susceptibility in fresh isolates of Plasmodium falciparum from subsaharan Africa. Mol. Biochem. Parasitol. 74:157-166.
5. Chaiyaroj, S. C., A. Buranakiti, P. Angkasekwinai, S. Looressuwan, and A. F. Cowman. 1999. Analysis of mefloquine resistance and amplification of pfmdr1 in multidrug-resistant Plasmodium falciparum isolates from Thailand. Am. J. Trop. Med. Hyg. 61:780-783.
6. Chavchich, M., L. Gerena, J. Peters, N. Chen, Q. Cheng, and D. E. Kyle. 2010. Role of pfmdr1 amplification and expression in induction of resistance to artemisinin derivatives in Plasmodium falciparum. Antimicrob. Agents Chemother. 54:2455-2464.
7. Cowman, A. F., D. Galatis, and J. K. Thompson. 1994. Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine. Proc. Natl. Acad. Sci. U. S. A. 91:1143-1147.
8. Desjardins, R. E., C. J. Canfield, J. D. Haynes, and J. D. Chulay. 1979. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob. Agents Chemother. 16:710-718.
9. Dondorp, A. M., F. Nosten, P. Yi, D. Das, A. P. Phyo, J. Tarning, K. M. Lwin, F. Ariey, W. Hanpithakpong, S. J. Lee, P. Ringwald, K. Silamut, M. Imwong, K. Chotivanich, P. Lim, T. Herdman, S. S. An, S. Yeung, P. Singhasivanon, N. P. Day, N. Lindegardh, D. Socheat, and N. J. White. 2009. Artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 361:455-467.
10. Gonzales, J. M., J. J. Patel, N. Ponmee, L. Jiang, A. Tan, S. P. Maher, S. Wuchty, P. K. Rathod, and M. T. Ferdig. 2008. Regulatory hotspots in the malaria parasite genome dictate transcriptional variation. PLoS Biol. 6:e238.
11. Hayward, R., K. J. Saliba, and K. Kirk. 2005. pfmdr1 mutations associated with chloroquine resistance incur a fitness cost in Plasmodium falciparum. Mol. Microbiol. 55:1285-1295.
12. Lambros, C., and J. P. Vanderberg. 1979. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J. Parasitol. 65:418-420.
13. Nair, S., D. Nash, D. Sudimack, A. Jaidee, M. Barends, A. C. Uhlemann, S. Krishna, F. Nosten, and T. J. Anderson. 2007. Recurrent gene amplification and soft selective sweeps during evolution of multidrug resistance in malaria parasites. Mol. Biol. Evol. 24:562-573.
14. Noedl, H., Y. Se, K. Schaecher, B. L. Smith, D. Socheat, and M. M. Fukuda. 2008. Evidence of artemisinin-resistant malaria in western Cambodia. N. Engl. J. Med. 359:2619-2620.
15. Peters, J. M., N. Chen, M. Gatton, M. Korsinczky, E. V. Fowler, S. Manzetti, A. Saul, and Q. Cheng. 2002. Mutations in cytochrome b resulting in atovaquone resistance are associated with loss of fitness in Plasmodium falciparum. Antimicrob. Agents Chemother. 46:2435-2441.
16. Preechapornkul, P., M. Imwong, K. Chotivanich, W. Pongtavornpinyo, A. M. Dondorp, N. P. Day, N. J. White, and S. Pukrittayakamee. 2009. Plasmodium falciparum pfmdr1 amplification, mefloquine resistance, and parasite fitness. Antimicrob. Agents Chemother. 53:1509-1515.
17. Price, R. N., A. C. Uhlemann, A. Brockman, R. McGready, E. Ashley, L. Phaipun, R. Patel, K. Laing, S. Looareesuwan, N. J. White, F. Nosten, and S. Krishna. 2004. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet 364:438-447.
18. Sidhu, A. B., A. C. Uhlemann, S. G. Valderramos, J. C. Valderramos, S. Krishna, and D. A. Fidock. 2006. Decreasing pfmdr1 copy number in plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin. J. Infect. Dis. 194:528-535.
19. Trager, W., and J. B. Jensen. 1976. Human malaria parasites in continuous culture. Science 193:673-675.
20. WHO. 2006. Guidelines for the treatment of malaria. World Health Organization, Geneva, Switzerland.
21. Wilson, C. M., A. E. Serrano, A. Wasley, M. P. Bogenschutz, A. H. Shankar, and D. F. Wirth. 1989. Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum. Science 244:1184-1186.
22. Wilson, C. M., S. K. Volkman, S. Thaithong, R. K. Martin, D. E. Kyle, W. K. Milhous, and D. F. Wirth. 1993. Amplification of pfmdr 1 associated with mefloquine and halofantrine resistance in Plasmodium falciparum from Thailand. Mol. Biochem. Parasitol. 57:151-160.